| Literature DB >> 18582813 |
Susan D Moffatt-Bruce1, Todd Pesavento, John Von Viger, David Nunley, Amy Pope-Harman, Stanley Martin, Patrick Ross.
Abstract
Hyperammonemia after lung transplantation is a rare complication of unknown etiology. Its management is largely supportive and outcomes have been variable. More disconcerting is its immunosuppressive management because the precipitating factors leading to this potentially lethal entity are unknown, but are suspected to be drug-related. We describe the successful management of a lung transplant recipient with severe hyperammonemia.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18582813 DOI: 10.1016/j.healun.2008.03.019
Source DB: PubMed Journal: J Heart Lung Transplant ISSN: 1053-2498 Impact factor: 10.247